A recommendation by the American Medical Association's Council on Ethical and Judicial Affairs to eliminate pharmaceutical industry funding from medical education was not approved by the AMA's Reference Committee, but could return in another form next year. After hearing all the testimony on June 15 at the AMA's annual House of Delegates meeting, AMA's Reference Committee recommended that the report, “Industry Support of Professional Education in Medicine,” be referred back to CEJA. The next ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Grant Ban Stalls, you'll get exclusive access to a large archive of premium content.

Already registered? here.